MediWound
MDWD | NASDAQ
$13.55
+$0.65 (+5.04%)
At close: Nov 16, 2026, 4:00 PM ET
$13.55
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
+5.04%
(1D)No price chart data available for 1D timeframe.
Rating
34.5
+7.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #669/1021 (Top 66%)
Key Statistics
Market Data
Market Cap $174.93M
1D Range
12.60 13.59
52W Range
11.85 19.37
Valuation (TTM)
PE -7.45
PB 5.50
EV/EBITDA -6.22
Valuation (NTM)
Forward PE N/A
Forward PEG 0.91
Price Target $28.50
Cash Flow
FCF Yield -18.6%
SBC Adj. FCF Yield -19.4%
SBC Impact -4.0%
Margins
Gross Margin 19.5%
Operating Margin -337.8%
FCF Margin -325.3%
Growth (CAGR)
Revenue 3Y | 5Y -26.3% |
-16.7%
Dil EPS 3Y | 5Y 24.5% |
15.3%
FCF 3Y | 5Y -22.4% |
-19.9%
Returns
ROA -35.9%
ROE -61.7%
ROIC -68.4%
Financial Health
Net Cash
$27.85M
Current Ratio 2.23
Interest Coverage -30.15
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germ...
Sector Healthcare
Industry Biotechnology
Employees 121
IPO Date Mar 20, 2014
Website www.mediwound.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.65
Beat +8.02%
YoY:
-170.83% REV
$3.57M
Miss -46.89%
YoY:
-34.19%Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$28.50
Upside
+110.33%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MDWD